06:07 EDT Alaunos Therapeutics (TCRT) files $50M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCRT:
- Alaunos Therapeutics Regains Nasdaq Compliance
- Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
- Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
- Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
- Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors